Overview

Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

Status:
Completed

Trial end date:
2010-03-01

Target enrollment:
0

Participant gender:
All

Summary

This observational study will be a documentation of the prescribing and administration practices of Enbrel® and their impact on ankylosing spondylitis patients outcome in a real life setting.

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Pfizer

Treatments:

Etanercept

Criteria

Inclusion Criteria:

- Proven diagnosis of Ankylosing Spondylitisin accordance with local guidelines

- Patients treated as an outpatient

Exclusion Criteria:

- Patients who suffer from hypersensitivity to the active substance Etanercept or to any
of the excipients of Enbrel®.

- Treatment with Enbrel® should not be initiated in patients with active infections
including chronic or localised infections.

- Patients with sepsis or risk of sepsis should not be treated.